These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 7770635)

  • 1. Recombinant human chromogranin A: expression, purification and characterization of the N-terminal derived peptides.
    Taupenot L; Remacle JE; Helle KB; Aunis D; Bader MF
    Regul Pept; 1995 Mar; 56(1):71-88. PubMed ID: 7770635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasostatins, comprising the N-terminal domain of chromogranin A, suppress tension in isolated human blood vessel segments.
    Aardal S; Helle KB; Elsayed S; Reed RK; Serck-Hanssen G
    J Neuroendocrinol; 1993 Aug; 5(4):405-12. PubMed ID: 8401564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracellular and extracellular processing of chromogranin A. Determination of cleavage sites.
    Metz-Boutigue MH; Garcia-Sablone P; Hogue-Angeletti R; Aunis D
    Eur J Biochem; 1993 Oct; 217(1):247-57. PubMed ID: 8223562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of natural vasostatin-containing peptides in rat heart.
    Glattard E; Angelone T; Strub JM; Corti A; Aunis D; Tota B; Metz-Boutigue MH; Goumon Y
    FEBS J; 2006 Jul; 273(14):3311-21. PubMed ID: 16857014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Processing of chromogranin B in bovine adrenal medulla. Identification of secretolytin, the endogenous C-terminal fragment of residues 614-626 with antibacterial activity.
    Strub JM; Garcia-Sablone P; Lonning K; Taupenot L; Hubert P; Van Dorsselaer A; Aunis D; Metz-Boutigue MH
    Eur J Biochem; 1995 Apr; 229(2):356-68. PubMed ID: 7744058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of calcium on recombinant bovine chromogranin A.
    Angeletti RH; Ali G; Shen N; Gee P; Nieves E
    Protein Sci; 1992 Dec; 1(12):1604-12. PubMed ID: 1304892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary sequence characterization of catestatin intermediates and peptides defines proteolytic cleavage sites utilized for converting chromogranin a into active catestatin secreted from neuroendocrine chromaffin cells.
    Lee JC; Taylor CV; Gaucher SP; Toneff T; Taupenot L; Yasothornsrikul S; Mahata SK; Sei C; Parmer RJ; Neveu JM; Lane WS; Gibson BW; O'Connor DT; Hook VY
    Biochemistry; 2003 Jun; 42(23):6938-46. PubMed ID: 12795588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasoinhibitory activity of synthetic peptides from the amino terminus of chromogranin A.
    Angeletti RH; Aardal S; Serck-Hanssen G; Gee P; Helle KB
    Acta Physiol Scand; 1994 Sep; 152(1):11-9. PubMed ID: 7810329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secretion from chromaffin cells is controlled by chromogranin A-derived peptides.
    Simon JP; Bader MF; Aunis D
    Proc Natl Acad Sci U S A; 1988 Mar; 85(5):1712-6. PubMed ID: 3422758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromogranin A epitopes: clues from synthetic peptides and peptide mapping.
    Gill BM; Barbosa JA; Hogue-Angeletti R; Varki N; O'Connor DT
    Neuropeptides; 1992 Feb; 21(2):105-18. PubMed ID: 1372966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterisation of N-terminal chromogranin A and chromogranin B in mammals by region-specific radioimmunoassays and chromatographic separation methods.
    Stridsberg M; Angeletti RH; Helle KB
    J Endocrinol; 2000 Jun; 165(3):703-14. PubMed ID: 10828855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PC12 cells show immunoreactivity to a number of proteins and peptides, including vasostatin.
    Cunningham RT; Pogue KM; Curry WJ; Johnston CF; Buchanan KD
    Peptides; 1996; 17(8):1297-301. PubMed ID: 8971922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bovine parathyroid glands secrete a 26-kDa N-terminal fragment of chromogranin-A which inhibits parathyroid cell secretion.
    Drees BM; Rouse J; Johnson J; Hamilton JW
    Endocrinology; 1991 Dec; 129(6):3381-7. PubMed ID: 1954912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The vasoinhibitory activity of bovine chromogranin A fragment (vasostatin) and its independence of extracellular calcium in isolated segments of human blood vessels.
    Aardal S; Helle KB
    Regul Pept; 1992 Sep; 41(1):9-18. PubMed ID: 1455014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromogranin A: posttranslational modifications in secretory granules.
    Barbosa JA; Gill BM; Takiyyuddin MA; O'Connor DT
    Endocrinology; 1991 Jan; 128(1):174-90. PubMed ID: 1986917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity of chromogranin A-derived peptides in bovine gut, pancreas and adrenal medulla.
    Watkinson A; Jönsson AC; Davison M; Young J; Lee CM; Moore S; Dockray GJ
    Biochem J; 1991 Jun; 276 ( Pt 2)(Pt 2):471-9. PubMed ID: 1710890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromostatin, a 20-amino acid peptide derived from chromogranin A, inhibits chromaffin cell secretion.
    Galindo E; Rill A; Bader MF; Aunis D
    Proc Natl Acad Sci U S A; 1991 Feb; 88(4):1426-30. PubMed ID: 1996343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromogranin A from bovine adrenal medulla: molecular characterization of glycosylations, phosphorylations, and sequence heterogeneities by mass spectrometry.
    Bauer SH; Zhang XY; Van Dongen W; Claeys M; Przybylski M
    Anal Biochem; 1999 Oct; 274(1):69-80. PubMed ID: 10527498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parastatin (porcine chromogranin A347-419), a novel chromogranin A-derived peptide, inhibits parathyroid cell secretion.
    Fasciotto BH; Trauss CA; Greeley GH; Cohn DV
    Endocrinology; 1993 Aug; 133(2):461-6. PubMed ID: 8344192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptides from the N-terminal domain of chromogranin A (vasostatins) exert negative inotropic effects in the isolated frog heart.
    Tota B; Mazza R; Angelone T; Nullans G; Metz-Boutigue MH; Aunis D; Helle KB
    Regul Pept; 2003 Jul; 114(2-3):123-30. PubMed ID: 12832100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.